Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01OYY
|
|||
| Drug Name |
PMID25656651-Compound-16a
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
NATCO PHARMA LIMITED KOMPELLA, Amala, Kishan RACHAKONDA, Sreenivas ADIBHATLA KALISATYA, Bhujanga, Rao VENKAIAH CHOWDARY, Nannapanen
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H17F6N5O
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)NC3=NC=CC(=N3)C4=CN=CC=C4
|
|||
| InChI |
1S/C25H17F6N5O/c1-14-4-5-19(12-21(14)36-23-33-8-6-20(35-23)15-3-2-7-32-13-15)34-22(37)16-9-17(24(26,27)28)11-18(10-16)25(29,30)31/h2-13H,1H3,(H,34,37)(H,33,35,36)
|
|||
| InChIKey |
LCPGCGAJBOWMIP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 879507-25-2
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.